Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vinorelbine in Elderly NSCLC
NCT00008333Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Apr 2001
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Cancer and Leukemia Group B. Primary endpoint: Objective Response Rate up to 5 years. Started Apr 2001; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00008333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008333.